David R. Bauer

Davis Polk is advising Roche Holding Ltd. in connection with the sale of an active pharmaceutical ingredients manufacturing facility in Florence, South Carolina, to Patheon N.V. Under the…

Davis Polk advised Advanced Accelerator Applications S.A. on its approximately $150 million SEC-registered follow-on offering of American Depositary Shares representing its ordinary shares…

Davis Polk advised AC Immune SA in connection with its $75.9 million U.S. initial public offering. AC Immune sold 6,900,000 of its common shares in the offering, which included 900,000…

Davis Polk is advising Chemtura Corporation in connection with its approximately $2.5 billion acquisition by LANXESS AG. The transaction, which is expected to close around mid-2017, is…

Davis Polk advised Shire plc on the $12.1 billion SEC-registered debt offering by its wholly owned subsidiary, Shire Acquisitions Investments Ireland DAC (“SAIIDAC”), consisting of $3.3…

Davis Polk is advising Comcast Corporation on its acquisition of Icontrol Networks, Inc. The transaction is expected to close by the end of 2016 and is subject to customary closing…

Davis Polk advised the representative of the underwriters in connection with the $181 million public offering of 4,025,000 shares of common stock of Spark Therapeutics, Inc. (“Spark”),…

Davis Polk is advising MERSCORP Holdings, Inc., owner of Mortgage Electronic Registrations Systems, Inc., on its acquisition by Intercontinental Exchange (ICE), the owner of the New York…

Davis Polk advised the joint bookrunners in connection with a Rule 144A offering by The Medicines Company of $402.5 million aggregate principal amount of 2.75% convertible senior notes due…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $112 million initial public offering by SecureWorks Corp. of 8,000,000 shares of…